Ending diarrheal deaths

Diarrhea sickens and kills more children than virtually any other illness. The Rotavirus Organization of Technical Allies (ROTA) Council is working to change this.
Learn More

Vaccine Introduction Maps

Find the latest maps of countries that have introduced rotavirus vaccine nationally and sub-nationally.

Learn More

Vaccine Impact

Significant declines in hospitalizations and deaths due to rotavirus and all-cause diarrhea have been observed in many countries using rotavirus vaccines.

Learn More

Advocacy Toolkit

Advocacy is critical to transforming evidence into action. We provide downloadable presentation materials, factsheets, guides for media engagement, and more.

Learn More

 What We Care About

Tremendous progress has been made in addressing morbidity and mortality from rotavirus disease. But more work is needed to reach all children who need rotavirus vaccines—particularly those living in low- and middle-income countries in Africa and Asia. That’s where we focus.

Our Goal: to accelerate the introduction of rotavirus vaccines through the use of evidence and strategic communications, targeting policymakers and other key decisions makers.

Meet the Council

Rotavirus Disease

Rotavirus is the most common cause of severe diarrhea. Learn about clinical aspects, prevention, treatment, and the global burden.

Learn More

Vaccine Evidence

Vaccination is the best way to prevent rotavirus disease. A growing body of evidence shows health and economic impacts.

Learn More

Vaccine Introduction

Find the latest introduction maps, country case studies, and preliminary information on vaccine financing to help governments begin planning.

Learn More

10.05.2017

New opportunities for preventing rotavirus in the region

An advocacy workshop in Hong Kong on the role of rotavirus vaccines in the Asia Pacific region

More Details

News

February – March 2017 Progress Update

Dear ROTA Council members, partners, and supporters, The evidence supporting rotavirus vaccine introduction continues to grow. A new study published today demonstrates the safety and efficacy of a new, live oral rotavirus vaccine, which, with other...

Upcoming Events

Building the investment case for rotavirus vaccines through evidence April 27, 2017 | 8:00 am – 1:00 pm Concorde Hotel, Singapore Held in conjunction with the Asian Vaccine Conference (ASVAC) A technical workshop to engage clinicians, researchers, and programmatic...